ArticleObesity surgery2026
Heart Failure Independently Predicts Higher Morbidity and Mortality Following Bariatric Surgery: Analysis of 180,544 MBSAQIP Cases.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHeart failure (HF) and obesity represent intersecting public health epidemics with significant healthcare implications. As obesity-related heart failure becomes increasingly prevalent, understanding the perioperative risks and outcomes of bariatric surgery in this vulnerable population is essential. This study aimed to analyze procedure-specific outcomes and cardiac complications in heart failure patients undergoing primary bariatric surgery using a large multi-institutional database. METHODS AND PROCEDURES: We conducted a retrospective analysis using the 2023 MBSAQIP database, examining adult patients who underwent primary laparoscopic bariatric procedures (sleeve gastrectomy or Roux-en-Y gastric bypass). Patients were stratified into heart failure and non-heart failure cohorts. The primary outcomes evaluated were 30-day serious complications and mortality. Multivariable logistic regression analyses were performed to identify independent predictors of complications and mortality, adjusting for demographics, comorbidities, and operative factors.
resultsAmong 180,544 patients, 2,842 (1.6%) had pre-existing heart failure documented preoperatively. HF patients were significantly older (53.3 ± 11.0 vs. 42.8 ± 11.8 years, p < 0.001) with higher BMI (48.6 ± 9.5 vs. 45.0 ± 7.7 kg/m², p < 0.001) and greater comorbidity burden. Procedure distribution was similar between groups (SG: 70.7% vs. 72.1%, RYGB: 29.3% vs. 27.9%, p = 0.091). HF patients experienced significantly higher rates of serious complications (7.2% vs. 2.4%, p < 0.001) and mortality (0.74% vs. 0.06%, p < 0.001). Cardiac events occurred 13 times more frequently in HF patients (1.3% vs. 0.1%, p < 0.001). Hospital length of stay was longer (1.9 ± 2.9 vs. 1.2 ± 1.0 days, p < 0.001), with higher readmission rates (7.8% vs. 2.8%, p < 0.001). On multivariable analysis, pre-existing HF was the strongest independent predictor of serious complications (OR 1.81; 95% CI 1.55–2.13; p < 0.001) and a powerful predictor of 30-day mortality (OR 3.64; 95% CI 2.14–6.20; p < 0.001).
conclusionHeart failure is a major independent predictor of both serious complications and mortality following bariatric surgery, occurring in nearly 2% of all elective cases. Despite the established long-term benefits of bariatric surgery for HF patients, the substantially elevated perioperative risks require careful patient selection, thorough preoperative cardiac assessment, and specialized perioperative management strategies to optimize outcomes in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.